CN103251987A - 一种脱细胞生物补片及其制备方法和装置 - Google Patents
一种脱细胞生物补片及其制备方法和装置 Download PDFInfo
- Publication number
- CN103251987A CN103251987A CN2013101175691A CN201310117569A CN103251987A CN 103251987 A CN103251987 A CN 103251987A CN 2013101175691 A CN2013101175691 A CN 2013101175691A CN 201310117569 A CN201310117569 A CN 201310117569A CN 103251987 A CN103251987 A CN 103251987A
- Authority
- CN
- China
- Prior art keywords
- cell
- sticking patch
- biological sticking
- preparation
- take
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 61
- 239000000463 material Substances 0.000 claims abstract description 75
- 210000000813 small intestine Anatomy 0.000 claims abstract description 44
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims abstract description 38
- 230000000694 effects Effects 0.000 claims abstract description 28
- 238000001035 drying Methods 0.000 claims abstract description 16
- 239000011259 mixed solution Substances 0.000 claims abstract description 15
- 239000002253 acid Substances 0.000 claims abstract description 14
- 239000000427 antigen Substances 0.000 claims abstract description 14
- 102000036639 antigens Human genes 0.000 claims abstract description 14
- 108091007433 antigens Proteins 0.000 claims abstract description 14
- 150000003839 salts Chemical class 0.000 claims abstract description 8
- 239000003513 alkali Substances 0.000 claims abstract description 6
- 210000004027 cell Anatomy 0.000 claims description 156
- 238000000034 method Methods 0.000 claims description 54
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 43
- 239000008213 purified water Substances 0.000 claims description 37
- 239000000243 solution Substances 0.000 claims description 26
- 230000000968 intestinal effect Effects 0.000 claims description 24
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 19
- 210000004347 intestinal mucosa Anatomy 0.000 claims description 17
- 239000011780 sodium chloride Substances 0.000 claims description 17
- -1 peroxide acetate Chemical class 0.000 claims description 14
- 230000008569 process Effects 0.000 claims description 14
- 150000001447 alkali salts Chemical class 0.000 claims description 12
- 239000007864 aqueous solution Substances 0.000 claims description 11
- 230000009514 concussion Effects 0.000 claims description 11
- 210000002826 placenta Anatomy 0.000 claims description 11
- 238000012545 processing Methods 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 239000012530 fluid Substances 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 8
- 239000012620 biological material Substances 0.000 claims description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 8
- 238000001291 vacuum drying Methods 0.000 claims description 8
- 230000001954 sterilising effect Effects 0.000 claims description 7
- 238000004659 sterilization and disinfection Methods 0.000 claims description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 6
- 239000004743 Polypropylene Substances 0.000 claims description 6
- 210000004876 tela submucosa Anatomy 0.000 claims description 6
- 230000001476 alcoholic effect Effects 0.000 claims description 5
- 210000001165 lymph node Anatomy 0.000 claims description 5
- 238000012856 packing Methods 0.000 claims description 5
- 229920001155 polypropylene Polymers 0.000 claims description 5
- 238000002203 pretreatment Methods 0.000 claims description 5
- 230000009967 tasteless effect Effects 0.000 claims description 5
- 230000008859 change Effects 0.000 claims description 4
- 239000004310 lactic acid Substances 0.000 claims description 4
- 235000014655 lactic acid Nutrition 0.000 claims description 4
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims description 3
- 235000017491 Bambusa tulda Nutrition 0.000 claims description 3
- 241001330002 Bambuseae Species 0.000 claims description 3
- 229920005479 Lucite® Polymers 0.000 claims description 3
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims description 3
- 239000011425 bamboo Substances 0.000 claims description 3
- 230000000295 complement effect Effects 0.000 claims description 3
- 239000007789 gas Substances 0.000 claims description 3
- 229950000845 politef Drugs 0.000 claims description 3
- 239000004926 polymethyl methacrylate Substances 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 229910000975 Carbon steel Inorganic materials 0.000 claims description 2
- 229910000831 Steel Inorganic materials 0.000 claims description 2
- 239000010962 carbon steel Substances 0.000 claims description 2
- 238000005457 optimization Methods 0.000 claims description 2
- 239000004033 plastic Substances 0.000 claims description 2
- 229920003023 plastic Polymers 0.000 claims description 2
- 238000002791 soaking Methods 0.000 claims description 2
- 239000010959 steel Substances 0.000 claims description 2
- 210000001519 tissue Anatomy 0.000 abstract description 30
- 230000008439 repair process Effects 0.000 abstract description 12
- 230000001900 immune effect Effects 0.000 abstract description 10
- 208000015181 infectious disease Diseases 0.000 abstract description 8
- 230000007547 defect Effects 0.000 abstract description 4
- 239000000853 adhesive Substances 0.000 abstract description 2
- 230000001070 adhesive effect Effects 0.000 abstract description 2
- 238000002513 implantation Methods 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 208000026137 Soft tissue injury Diseases 0.000 abstract 1
- 241000282887 Suidae Species 0.000 abstract 1
- 206010052428 Wound Diseases 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 230000028709 inflammatory response Effects 0.000 abstract 1
- 231100000956 nontoxicity Toxicity 0.000 abstract 1
- 238000004064 recycling Methods 0.000 abstract 1
- 230000003014 reinforcing effect Effects 0.000 abstract 1
- 230000004044 response Effects 0.000 abstract 1
- 235000002639 sodium chloride Nutrition 0.000 description 19
- 102000004169 proteins and genes Human genes 0.000 description 15
- 108090000623 proteins and genes Proteins 0.000 description 15
- 238000001727 in vivo Methods 0.000 description 14
- 241000282472 Canis lupus familiaris Species 0.000 description 13
- 241000700159 Rattus Species 0.000 description 13
- 238000002474 experimental method Methods 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 208000021970 Abdominal wall defect Diseases 0.000 description 10
- 108010035532 Collagen Proteins 0.000 description 10
- 102000008186 Collagen Human genes 0.000 description 10
- 206010061218 Inflammation Diseases 0.000 description 10
- 238000004140 cleaning Methods 0.000 description 10
- 230000004054 inflammatory process Effects 0.000 description 10
- 208000029836 Inguinal Hernia Diseases 0.000 description 9
- 229920001436 collagen Polymers 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 8
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 8
- 241000700605 Viruses Species 0.000 description 8
- 210000002744 extracellular matrix Anatomy 0.000 description 8
- 239000002131 composite material Substances 0.000 description 7
- 238000007598 dipping method Methods 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 6
- 239000004141 Sodium laurylsulphate Substances 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 239000007943 implant Substances 0.000 description 6
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 6
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 5
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 5
- 102000013275 Somatomedins Human genes 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 238000004108 freeze drying Methods 0.000 description 5
- 238000007654 immersion Methods 0.000 description 5
- 238000007912 intraperitoneal administration Methods 0.000 description 5
- 229920002994 synthetic fiber Polymers 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- 230000034994 death Effects 0.000 description 4
- 238000002224 dissection Methods 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000002779 inactivation Effects 0.000 description 4
- 210000002027 skeletal muscle Anatomy 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 206010068676 Pneumoretroperitoneum Diseases 0.000 description 3
- 208000005727 Retropneumoperitoneum Diseases 0.000 description 3
- 238000010306 acid treatment Methods 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 230000003013 cytotoxicity Effects 0.000 description 3
- 231100000135 cytotoxicity Toxicity 0.000 description 3
- 239000003599 detergent Substances 0.000 description 3
- 238000006073 displacement reaction Methods 0.000 description 3
- 238000004043 dyeing Methods 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 210000002950 fibroblast Anatomy 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 230000008520 organization Effects 0.000 description 3
- DHRLEVQXOMLTIM-UHFFFAOYSA-N phosphoric acid;trioxomolybdenum Chemical compound O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.OP(O)(O)=O DHRLEVQXOMLTIM-UHFFFAOYSA-N 0.000 description 3
- 230000002980 postoperative effect Effects 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- 210000004267 spermatic cord Anatomy 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000007920 subcutaneous administration Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 206010000050 Abdominal adhesions Diseases 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 208000005422 Foreign-Body reaction Diseases 0.000 description 2
- 206010019909 Hernia Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 229920000954 Polyglycolide Polymers 0.000 description 2
- 241000701093 Suid alphaherpesvirus 1 Species 0.000 description 2
- 208000031737 Tissue Adhesions Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 238000009954 braiding Methods 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 208000037976 chronic inflammation Diseases 0.000 description 2
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 239000004633 polyglycolic acid Substances 0.000 description 2
- 239000004626 polylactic acid Substances 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 229960002668 sodium chloride Drugs 0.000 description 2
- 235000011121 sodium hydroxide Nutrition 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 108010070228 surgisis Proteins 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 238000010200 validation analysis Methods 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 238000004804 winding Methods 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 208000000094 Chronic Pain Diseases 0.000 description 1
- 102000012432 Collagen Type V Human genes 0.000 description 1
- 108010022514 Collagen Type V Proteins 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 229920004934 Dacron® Polymers 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- 208000027536 Femoral Hernia Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 241000521257 Hydrops Species 0.000 description 1
- 208000008081 Intestinal Fistula Diseases 0.000 description 1
- 206010059017 Intestinal mass Diseases 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 239000002998 adhesive polymer Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 244000144987 brood Species 0.000 description 1
- 239000003715 calcium chelating agent Substances 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000003693 cell processing method Methods 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 238000002316 cosmetic surgery Methods 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 239000003398 denaturant Substances 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000000280 densification Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 210000001951 dura mater Anatomy 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 210000000003 hoof Anatomy 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000030198 regulation of embryonic development Effects 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Images
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310117569.1A CN103251987B (zh) | 2013-04-07 | 2013-04-07 | 一种脱细胞生物补片及其制备方法和装置 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310117569.1A CN103251987B (zh) | 2013-04-07 | 2013-04-07 | 一种脱细胞生物补片及其制备方法和装置 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103251987A true CN103251987A (zh) | 2013-08-21 |
CN103251987B CN103251987B (zh) | 2014-12-31 |
Family
ID=48956408
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310117569.1A Active CN103251987B (zh) | 2013-04-07 | 2013-04-07 | 一种脱细胞生物补片及其制备方法和装置 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103251987B (zh) |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103893823A (zh) * | 2014-04-04 | 2014-07-02 | 江苏期佰医疗技术有限公司 | 一种高活性生物衍生材料及其制备方法与应用 |
CN105126171A (zh) * | 2015-08-27 | 2015-12-09 | 中国人民解放军第三军医大学 | 一种具有形状记忆功能的凝胶生物材料及其制备方法 |
CN105664257A (zh) * | 2016-03-01 | 2016-06-15 | 上海卓阮医疗科技有限公司 | 一种修复区稳固的复合软组织修复材料 |
CN105726160A (zh) * | 2016-04-29 | 2016-07-06 | 陕西瑞盛生物科技有限公司 | 一种生物补片的复水方法以及复水后的生物补片 |
CN105999411A (zh) * | 2016-05-23 | 2016-10-12 | 苏州恒瑞迪生医疗科技有限公司 | 一种疝补片及其制备方法 |
CN106039405A (zh) * | 2015-04-08 | 2016-10-26 | 上海宏创医疗科技有限公司 | 一种细胞外基质复合生物补片的制备方法 |
CN106039404A (zh) * | 2015-04-08 | 2016-10-26 | 上海宏创医疗科技有限公司 | 一种细胞外基质复合生物补片的制备方法 |
CN106267347A (zh) * | 2016-08-16 | 2017-01-04 | 北京大清生物技术有限公司 | 盆底生物补片及其制备方法 |
CN107012085A (zh) * | 2017-05-31 | 2017-08-04 | 陕西瑞盛生物科技有限公司 | 一种自动补液式脱细胞系统及方法 |
CN107875454A (zh) * | 2017-11-27 | 2018-04-06 | 北京大清生物技术股份有限公司 | 一种用于引导组织再生的胶原复合膜及其制备方法与应用 |
CN108478870A (zh) * | 2017-07-12 | 2018-09-04 | 上海白衣缘生物工程有限公司 | 一种硬膜生物补片及其制备方法 |
CN108837184A (zh) * | 2017-07-12 | 2018-11-20 | 上海白衣缘生物工程有限公司 | 一种用于引导骨再生的复合膜及其制备方法 |
CN109364299A (zh) * | 2018-11-28 | 2019-02-22 | 上海白衣缘生物工程有限公司 | 一种盆底生物修补网片及其制备方法 |
CN110559485A (zh) * | 2019-09-25 | 2019-12-13 | 北京大清生物技术股份有限公司 | 一种生物组织基质材料及其制备方法与应用 |
CN112641999A (zh) * | 2020-12-04 | 2021-04-13 | 陕西佰傲再生医学有限公司 | 一种铺膜设备及其应用 |
CN113456675A (zh) * | 2021-07-26 | 2021-10-01 | 山东大学齐鲁医院 | 脱细胞sis在抑制青光眼术后瘢痕组织增生中的应用 |
CN114699565A (zh) * | 2022-03-31 | 2022-07-05 | 杭州恒正医源生物科技有限公司 | 生物补片及其制备方法 |
CN116808306A (zh) * | 2023-08-08 | 2023-09-29 | 北京万洁天元医疗器械股份有限公司 | 用于受损软组织修复的再生型生物补片及制备方法和应用 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040002723A1 (en) * | 2002-06-27 | 2004-01-01 | Robert Ball | Method and apparatus for implantation of soft tissue implant |
CN1562388A (zh) * | 2004-04-15 | 2005-01-12 | 深圳市清华源兴生物医药科技有限公司 | 一种口腔组织补片及其制作方法与应用 |
US20070014873A1 (en) * | 2005-07-15 | 2007-01-18 | Cormatrix Cardiovascular, Inc. | Compositions for regenerating defective or absent myocardium |
CN101366979A (zh) * | 2008-09-03 | 2009-02-18 | 陕西瑞盛生物科技有限公司 | 一种组织补片及其制备方法 |
CN101623518A (zh) * | 2009-06-30 | 2010-01-13 | 中国人民解放军第二军医大学 | 一种抗感染生物衍生疝和体壁修复材料及制备和应用 |
CN201664349U (zh) * | 2009-06-30 | 2010-12-08 | 中国人民解放军第二军医大学 | 一种新型复合疝和体壁修补片 |
CN102462561A (zh) * | 2010-11-19 | 2012-05-23 | 北京迈迪顶峰医疗科技有限公司 | 一种sis软组织修复补片及其制备方法 |
-
2013
- 2013-04-07 CN CN201310117569.1A patent/CN103251987B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040002723A1 (en) * | 2002-06-27 | 2004-01-01 | Robert Ball | Method and apparatus for implantation of soft tissue implant |
CN1562388A (zh) * | 2004-04-15 | 2005-01-12 | 深圳市清华源兴生物医药科技有限公司 | 一种口腔组织补片及其制作方法与应用 |
US20070014873A1 (en) * | 2005-07-15 | 2007-01-18 | Cormatrix Cardiovascular, Inc. | Compositions for regenerating defective or absent myocardium |
CN101366979A (zh) * | 2008-09-03 | 2009-02-18 | 陕西瑞盛生物科技有限公司 | 一种组织补片及其制备方法 |
CN101623518A (zh) * | 2009-06-30 | 2010-01-13 | 中国人民解放军第二军医大学 | 一种抗感染生物衍生疝和体壁修复材料及制备和应用 |
CN201664349U (zh) * | 2009-06-30 | 2010-12-08 | 中国人民解放军第二军医大学 | 一种新型复合疝和体壁修补片 |
CN102462561A (zh) * | 2010-11-19 | 2012-05-23 | 北京迈迪顶峰医疗科技有限公司 | 一种sis软组织修复补片及其制备方法 |
Non-Patent Citations (1)
Title |
---|
冯超: "小肠粘膜下组织应用于尿路修复重建中的进展", 《国外医学泌尿系统分册》 * |
Cited By (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103893823B (zh) * | 2014-04-04 | 2016-08-31 | 江苏期佰医疗技术有限公司 | 一种高活性生物衍生材料及其制备方法与应用 |
CN103893823A (zh) * | 2014-04-04 | 2014-07-02 | 江苏期佰医疗技术有限公司 | 一种高活性生物衍生材料及其制备方法与应用 |
CN106039405A (zh) * | 2015-04-08 | 2016-10-26 | 上海宏创医疗科技有限公司 | 一种细胞外基质复合生物补片的制备方法 |
CN106039404A (zh) * | 2015-04-08 | 2016-10-26 | 上海宏创医疗科技有限公司 | 一种细胞外基质复合生物补片的制备方法 |
CN105126171A (zh) * | 2015-08-27 | 2015-12-09 | 中国人民解放军第三军医大学 | 一种具有形状记忆功能的凝胶生物材料及其制备方法 |
CN105664257B (zh) * | 2016-03-01 | 2019-02-19 | 上海卓阮医疗科技有限公司 | 一种修复区稳固的复合软组织修复材料 |
CN105664257A (zh) * | 2016-03-01 | 2016-06-15 | 上海卓阮医疗科技有限公司 | 一种修复区稳固的复合软组织修复材料 |
CN105726160A (zh) * | 2016-04-29 | 2016-07-06 | 陕西瑞盛生物科技有限公司 | 一种生物补片的复水方法以及复水后的生物补片 |
CN105999411A (zh) * | 2016-05-23 | 2016-10-12 | 苏州恒瑞迪生医疗科技有限公司 | 一种疝补片及其制备方法 |
CN105999411B (zh) * | 2016-05-23 | 2019-08-30 | 苏州恒瑞迪生医疗科技有限公司 | 一种疝补片及其制备方法 |
CN106267347A (zh) * | 2016-08-16 | 2017-01-04 | 北京大清生物技术有限公司 | 盆底生物补片及其制备方法 |
CN106267347B (zh) * | 2016-08-16 | 2019-07-12 | 北京大清生物技术股份有限公司 | 盆底生物补片及其制备方法 |
CN107012085B (zh) * | 2017-05-31 | 2020-01-03 | 陕西瑞盛生物科技有限公司 | 一种自动补液式脱细胞系统及方法 |
CN107012085A (zh) * | 2017-05-31 | 2017-08-04 | 陕西瑞盛生物科技有限公司 | 一种自动补液式脱细胞系统及方法 |
CN108837184A (zh) * | 2017-07-12 | 2018-11-20 | 上海白衣缘生物工程有限公司 | 一种用于引导骨再生的复合膜及其制备方法 |
CN108478870A (zh) * | 2017-07-12 | 2018-09-04 | 上海白衣缘生物工程有限公司 | 一种硬膜生物补片及其制备方法 |
CN107875454B (zh) * | 2017-11-27 | 2020-12-11 | 北京大清生物技术股份有限公司 | 一种用于引导组织再生的胶原复合膜及其制备方法与应用 |
CN107875454A (zh) * | 2017-11-27 | 2018-04-06 | 北京大清生物技术股份有限公司 | 一种用于引导组织再生的胶原复合膜及其制备方法与应用 |
CN109364299A (zh) * | 2018-11-28 | 2019-02-22 | 上海白衣缘生物工程有限公司 | 一种盆底生物修补网片及其制备方法 |
CN109364299B (zh) * | 2018-11-28 | 2021-06-01 | 上海白衣缘生物工程有限公司 | 一种盆底生物修补网片及其制备方法 |
CN110559485A (zh) * | 2019-09-25 | 2019-12-13 | 北京大清生物技术股份有限公司 | 一种生物组织基质材料及其制备方法与应用 |
CN112641999A (zh) * | 2020-12-04 | 2021-04-13 | 陕西佰傲再生医学有限公司 | 一种铺膜设备及其应用 |
CN112641999B (zh) * | 2020-12-04 | 2022-10-04 | 陕西佰傲再生医学有限公司 | 一种铺膜设备及其应用 |
CN113456675A (zh) * | 2021-07-26 | 2021-10-01 | 山东大学齐鲁医院 | 脱细胞sis在抑制青光眼术后瘢痕组织增生中的应用 |
CN114699565A (zh) * | 2022-03-31 | 2022-07-05 | 杭州恒正医源生物科技有限公司 | 生物补片及其制备方法 |
CN116808306A (zh) * | 2023-08-08 | 2023-09-29 | 北京万洁天元医疗器械股份有限公司 | 用于受损软组织修复的再生型生物补片及制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN103251987B (zh) | 2014-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103251987B (zh) | 一种脱细胞生物补片及其制备方法和装置 | |
US10426868B2 (en) | Method for preparing an animal decellularized tissue matrix material and a decellularized tissue matrix material prepared thereby | |
CN101366975B (zh) | 脱细胞小肠粘膜下层生物材料的制备方法 | |
EP1623681B1 (en) | Peracetic acid crosslinked non-antigenic icl grafts | |
US7909886B2 (en) | Tissue repair fabric | |
JP4606583B2 (ja) | 生物工学的手法による平面シート状移植補綴 | |
CN104971380B (zh) | 一种脱细胞基质修复凝胶及其制备新方法 | |
AU2001291092B2 (en) | Bioengineered flat sheet graft prosthesis and its use | |
CN102462561A (zh) | 一种sis软组织修复补片及其制备方法 | |
AU2001291092A1 (en) | Bioengineered flat sheet graft prosthesis and its use | |
CN205073351U (zh) | 一种脱细胞基质源的口腔补片 | |
CN202283366U (zh) | 一种sis软组织修复补片 | |
CN105983094A (zh) | 一种具有生物活性的无菌胶原液和无菌胶原贴敷料的制备方法 | |
CN101366979A (zh) | 一种组织补片及其制备方法 | |
CN102727935A (zh) | 硬脑/脊膜移植替代物的制备方法及其装置 | |
CN107823710A (zh) | 一种高生物活性的细胞外基质材料及其制备方法和应用 | |
CN104399120A (zh) | 一种胶原膜的制备方法及胶原膜 | |
CN108114320A (zh) | 组织修复用补片、主体及制备方法 | |
CN107050529A (zh) | 一种宫腔内置物、制备方法及其应用 | |
CN105363073B (zh) | 含生物活性因子的组织工程软骨支架及其制备方法与应用 | |
CN210698333U (zh) | 一种软组织生物修补网片 | |
Guide | Dedicated to.... My | |
CN111450320A (zh) | 生物组织腹壁缺损修复材料 | |
MXPA97007655A (en) | Tej repair fabric |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Acellular biological patch, preparation method and apparatus thereof Effective date of registration: 20151221 Granted publication date: 20141231 Pledgee: Xianyang financing Company Limited by Guarantee Pledgor: SHAANXI BIO REGENERATIVE MEDICINE Co.,Ltd. Registration number: 2015990001138 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20170113 Granted publication date: 20141231 Pledgee: Xianyang financing guarantee Limited by Share Ltd. Pledgor: SHAANXI BIO REGENERATIVE MEDICINE Co.,Ltd. Registration number: 2015990001138 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PM01 | Change of the registration of the contract for pledge of patent right |
Change date: 20170113 Registration number: 2015990001138 Pledgee after: Xianyang financing guarantee Limited by Share Ltd. Pledgee before: Xianyang financing Company Limited by Guarantee |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Acellular biological patch, preparation method and apparatus thereof Effective date of registration: 20170420 Granted publication date: 20141231 Pledgee: Xianyang financing guarantee Limited by Share Ltd. Pledgor: SHAANXI BIO REGENERATIVE MEDICINE Co.,Ltd. Registration number: 2017990000327 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20180611 Granted publication date: 20141231 Pledgee: Xianyang financing guarantee Limited by Share Ltd. Pledgor: SHAANXI BIO REGENERATIVE MEDICINE Co.,Ltd. Registration number: 2017990000327 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Acellular biological patch, preparation method and apparatus thereof Effective date of registration: 20180611 Granted publication date: 20141231 Pledgee: Xianyang financing guarantee Limited by Share Ltd. Pledgor: SHAANXI BIO REGENERATIVE MEDICINE Co.,Ltd. Registration number: 2018990000439 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20190701 Granted publication date: 20141231 Pledgee: Xianyang financing guarantee Limited by Share Ltd. Pledgor: SHAANXI BIO REGENERATIVE MEDICINE Co.,Ltd. Registration number: 2018990000439 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Acellular biological patch, preparation method and apparatus thereof Effective date of registration: 20190701 Granted publication date: 20141231 Pledgee: Xianyang financing guarantee Limited by Share Ltd. Pledgor: SHAANXI BIO REGENERATIVE MEDICINE Co.,Ltd. Registration number: 2019990000643 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20200915 Granted publication date: 20141231 Pledgee: Xianyang financing guarantee Limited by Share Ltd. Pledgor: SHAANXI BIO REGENERATIVE MEDICINE Co.,Ltd. Registration number: 2019990000643 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: An acellular biological patch and its preparation method and device Effective date of registration: 20201106 Granted publication date: 20141231 Pledgee: CITIC Bank Limited by Share Ltd. Xi'an branch Pledgor: SHAANXI BIO REGENERATIVE MEDICINE Co.,Ltd. Registration number: Y2020610000198 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230825 Granted publication date: 20141231 Pledgee: CITIC Bank Limited by Share Ltd. Xi'an branch Pledgor: SHAANXI BIO REGENERATIVE MEDICINE Co.,Ltd. Registration number: Y2020610000198 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |